Justin Bowers
Stock Analyst at Deutsche Bank
(3.35)
# 1,066
Out of 4,435 analysts
38
Total ratings
41.94%
Success rate
6.38%
Average return
Main Sectors:
17 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FTRE Fortrea Holdings | Maintains: Hold | $36 → $28 | $25.39 | +10.28% | 2 | May 23, 2024 | |
| TMO Thermo Fisher | Maintains: Buy | $600 → $610 | $567.98 | +7.40% | 3 | Apr 25, 2024 | |
| TXG 10x Genomics | Maintains: Buy | $60 → $55 | $22.42 | +145.32% | 2 | Apr 18, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $77.19 | +6.23% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Maintains: Hold | $23 → $25 | $24.08 | +3.82% | 3 | Apr 18, 2024 | |
| MEDP Medpace Holdings | Initiates: Hold | $395 | $386.34 | +2.24% | 1 | Mar 18, 2024 | |
| CTLT Catalent | Maintains: Hold | $37 → $45 | $53.79 | -16.34% | 8 | Aug 15, 2023 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $23 → $17 | $8.67 | +96.08% | 3 | Aug 8, 2023 | |
| ICLR ICON PLC | Maintains: Buy | $280 → $300 | $324.82 | -7.64% | 2 | Jul 14, 2023 | |
| DHR Danaher | Maintains: Buy | $310 → $275 | $256.80 | +7.09% | 2 | Apr 27, 2023 | |
| RGEN Repligen | Initiates: Hold | $180 | $149.09 | +20.73% | 1 | Dec 14, 2022 | |
| WAT Waters | Initiates: Hold | $350 | $308.90 | +13.31% | 1 | Dec 14, 2022 | |
| WST West Pharmaceutical Services | Initiates: Hold | $250 | $331.41 | -24.56% | 1 | Dec 14, 2022 | |
| AMED Amedisys | Maintains: Buy | $175 → $165 | $91.15 | +81.02% | 3 | Oct 24, 2022 | |
| CRL Charles River Laboratories International | Maintains: Buy | $350 → $290 | $208.44 | +39.13% | 1 | Jul 14, 2022 | |
| IQV IQVIA Holdings | Maintains: Buy | $250 → $290 | $219.09 | +32.37% | 1 | Apr 12, 2022 | |
| SEM Select Medical Holdings | Maintains: Buy | n/a | $34.55 | - | 2 | Apr 24, 2020 |
Fortrea Holdings
May 23, 2024
Maintains: Hold
Price Target: $36 → $28
Current: $25.39
Upside: +10.28%
Thermo Fisher
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $567.98
Upside: +7.40%
10x Genomics
Apr 18, 2024
Maintains: Buy
Price Target: $60 → $55
Current: $22.42
Upside: +145.32%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $77.19
Upside: +6.23%
Avantor
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $24.08
Upside: +3.82%
Medpace Holdings
Mar 18, 2024
Initiates: Hold
Price Target: $395
Current: $386.34
Upside: +2.24%
Catalent
Aug 15, 2023
Maintains: Hold
Price Target: $37 → $45
Current: $53.79
Upside: -16.34%
Maravai LifeSciences Holdings
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $8.67
Upside: +96.08%
ICON PLC
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $324.82
Upside: -7.64%
Danaher
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $256.80
Upside: +7.09%
Repligen
Dec 14, 2022
Initiates: Hold
Price Target: $180
Current: $149.09
Upside: +20.73%
Waters
Dec 14, 2022
Initiates: Hold
Price Target: $350
Current: $308.90
Upside: +13.31%
West Pharmaceutical Services
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $331.41
Upside: -24.56%
Amedisys
Oct 24, 2022
Maintains: Buy
Price Target: $175 → $165
Current: $91.15
Upside: +81.02%
Charles River Laboratories International
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $208.44
Upside: +39.13%
IQVIA Holdings
Apr 12, 2022
Maintains: Buy
Price Target: $250 → $290
Current: $219.09
Upside: +32.37%
Select Medical Holdings
Apr 24, 2020
Maintains: Buy
Price Target: n/a
Current: $34.55
Upside: -